Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study

NCT05452187 · clinicaltrials.gov ↗

COMPLETED

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases
Hepatitis C Virus Infection

Interventions

DRUG: Assess the effectiveness and safety of DAAs in patients with IBD.
DRUG: Evaluate the interaction of DAAs with IBD drugs, particularly immunosuppressants and/or biologics.
OTHER: Assessment of the impact of DAAs on the course of IBD.

Sponsor

Hospital Mutua de Terrassa